132 related articles for article (PubMed ID: 1650143)
1. Vasopressin receptor-mediated endocytosis: current view.
Lutz W; Salisbury JL; Kumar R
Am J Physiol; 1991 Jul; 261(1 Pt 2):F1-13. PubMed ID: 1650143
[TBL] [Abstract][Full Text] [Related]
2. Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells with V2 or V1 receptors.
Lutz W; Sanders M; Salisbury J; Kumar R
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6507-11. PubMed ID: 2144348
[TBL] [Abstract][Full Text] [Related]
3. Internalization of V2-vasopressin receptors in LLC-PK1-cells: evidence for receptor-mediated endocytosis.
Hocher B; Merker HJ; Dürr JA; Schiller S; Gross P; Hensen J
Biochem Biophys Res Commun; 1992 Aug; 186(3):1376-83. PubMed ID: 1387309
[TBL] [Abstract][Full Text] [Related]
4. A vasopressin analog that binds but does not activate V1 or V2 vasopressin receptors is not internalized into cells that express V1 or V2 receptors.
Lutz W; Londowski JM; Sanders M; Salisbury J; Kumar R
J Biol Chem; 1992 Jan; 267(2):1109-15. PubMed ID: 1309761
[TBL] [Abstract][Full Text] [Related]
5. Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment.
Bouley R; Hawthorn G; Russo LM; Lin HY; Ausiello DA; Brown D
Biol Cell; 2006 Apr; 98(4):215-32. PubMed ID: 16563128
[TBL] [Abstract][Full Text] [Related]
6. Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells.
Bouley R; Sun TX; Chenard M; McLaughlin M; McKee M; Lin HY; Brown D; Ausiello DA
Am J Physiol Cell Physiol; 2003 Oct; 285(4):C750-62. PubMed ID: 12801889
[TBL] [Abstract][Full Text] [Related]
7. Receptor cell biology: receptor-mediated endocytosis.
Schwartz AL
Pediatr Res; 1995 Dec; 38(6):835-43. PubMed ID: 8618782
[TBL] [Abstract][Full Text] [Related]
8. cAMP-dependent protein kinase activation affects vasopressin V2-receptor number and internalization in LLC-PK1 renal epithelial cells.
Jans DA; Hemmings BA
FEBS Lett; 1991 Apr; 281(1-2):267-71. PubMed ID: 1707831
[TBL] [Abstract][Full Text] [Related]
9. Complementation between LLC-PK1 mutants affected in polypeptide hormone-receptor function.
Jans DA; Resink TJ; Hemmings BA
Eur J Biochem; 1987 Feb; 162(3):571-6. PubMed ID: 3030741
[TBL] [Abstract][Full Text] [Related]
10. Monensin-resistant LLC-PK1 cell mutants are affected in recycling of the adenylate cyclase-stimulating vasopressin V2-receptor.
Jans DA; Jans P; Luzius H; Fahrenholz F
Mol Cell Endocrinol; 1991 Oct; 81(1-3):165-74. PubMed ID: 1797584
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin increases cytosolic free calcium in LLC-PK1 cells through a V1-receptor.
Burnatowska-Hledin MA; Spielman WS
Am J Physiol; 1987 Aug; 253(2 Pt 2):F328-32. PubMed ID: 2956892
[TBL] [Abstract][Full Text] [Related]
12. The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature.
Jans DA; Peters R; Zsigo J; Fahrenholz F
EMBO J; 1989 Sep; 8(9):2481-8. PubMed ID: 2531084
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin V2-receptor mobile fraction and ligand-dependent adenylate cyclase activity are directly correlated in LLC-PK1 renal epithelial cells.
Jans DA; Peters R; Jans P; Fahrenholz F
J Cell Biol; 1991 Jul; 114(1):53-60. PubMed ID: 1646825
[TBL] [Abstract][Full Text] [Related]
14. Biotinyl analogues of vasopressin as biologically active probes for vasopressin receptor expression in cultured cells.
Jans DA; Bergmann L; Peters R; Fahrenholz F
J Biol Chem; 1990 Aug; 265(24):14599-605. PubMed ID: 2143764
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
Stassen FL; Heckman G; Schmidt D; Papadopoulos MT; Nambi P; Sarau H; Aiyar N; Gellai M; Kinter L
Mol Pharmacol; 1988 Feb; 33(2):218-24. PubMed ID: 2828915
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin receptor-mediated endocytosis in cells transfected with V1-type vasopressin receptors.
Lutz W; Sanders M; Salisbury J; Lolait S; O'Carroll AM; Kumar R
Kidney Int; 1993 Apr; 43(4):845-52. PubMed ID: 8479120
[TBL] [Abstract][Full Text] [Related]
17. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
Liard JF
Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
[TBL] [Abstract][Full Text] [Related]
18. Iodination of vasopressin analogues with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors.
Jard S; Lombard C; Seyer R; Aumelas A; Manning M; Sawyer WH
Mol Pharmacol; 1987 Sep; 32(3):369-75. PubMed ID: 2959851
[TBL] [Abstract][Full Text] [Related]
19. Ammonium chloride affects receptor number and lateral mobility of the vasopressin V2-type receptor in the plasma membrane of LLC-PK1 renal epithelial cells: role of the cytoskeleton.
Jans DA; Peters R; Jans P; Fahrenholz F
Exp Cell Res; 1990 Nov; 191(1):121-8. PubMed ID: 2146138
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.
Jard S; Gaillard RC; Guillon G; Marie J; Schoenenberg P; Muller AF; Manning M; Sawyer WH
Mol Pharmacol; 1986 Aug; 30(2):171-7. PubMed ID: 3016500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
